Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35.
BACKGROUND
Type 2 diabetes mellitus (T2DM) is a common disease with numerous complications. Bariatric surgery is an efficient procedure for controlling T2DM in morbidly obese patients. In T2DM, the incretin effect is either greatly impaired or absent. This study aimed to evaluate the preliminary results from interposing a segment of ileum into the proximal jejunum associated with a sleeve or diverted sleeve gastrectomy to control T2DM in patients with a body mass index (BMI) less than 35 kg/m(2).


METHODS
For this study, 39 patients (16 women and 23 men) underwent two laparoscopic procedures comprising different combinations of ileal interposition into the proximal jejunum via a sleeve or diverted sleeve gastrectomy. The mean age of these patients was 50.3 years (range, 36-66 years). The mean BMI was 30.1 kg/m(2) (range, 23.4-34.9 kg/m(2)). All the patients had a diagnosis of T2DM that had persisted for at least 3 years and evidence of stable treatment with oral hypoglycemic agents or insulin for at least 12 months. The mean duration of T2DM was 9.3 years (range, 3-22 years).


RESULTS
The mean operative time was 185 min, and the median hospital stay was 4.3 days. Four major complications occurred in the short term (30-days), and the mortality rate was 2.6%. The mean postoperative follow-up period was 7 months (range, 4-16 months), and the mean percentage of weight loss was 22%. The mean postoperative BMI was 24.9 kg/m(2) (range, 18.9-31.7 kg/m(2)). An adequate glycemic control was achieved for 86.9% of the patients, and 13.1% had important improvement. The patients whose glycemia was not normalized were using a single oral hypoglycemic agent. No patient needed insulin therapy postoperatively. All the patients except experienced normalization of their cholesterol levels. Targeted triglycerides levels were achieved by 71% of the patients, and hypertension was controlled for 95.8%.


CONCLUSIONS
The laparoscopic ileal interposition via either a sleeve gastrectomy or diverted sleeve gastrectomy seems to be a promising procedure for the control of T2DM and the metabolic syndrome. A longer follow-up period is needed.
DePaula
A L
AL
Department of Surgery, Hospital de Especialidades, Goiânia, Brazil. adepaula@uol.com.br
Macedo
A L V
AL
Rassi
N
N
Machado
C A
CA
Schraibman
V
V
Silva
L Q
LQ
Halpern
A
A
D000328:Adult; D000368:Aged; D000714:Anastomosis, Surgical / Q000379:methods; D001786:Blood Glucose / Q000032:analysis; D015992:Body Mass Index; D015331:Cohort Studies; D015897:Comorbidity; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000453:epidemiology*; D005260:Female; D005500:Follow-Up Studies; D015390:Gastric Bypass / Q000379:methods*; D006801:Humans; D007082:Ileum / Q000601:surgery; D010535:Laparoscopy / Q000009:adverse effects / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000175:diagnosis / Q000453:epidemiology* / Q000601:surgery*; D011183:Postoperative Complications / Q000503:physiopathology; D011336:Probability; D011788:Quality of Life; D018570:Risk Assessment; D013270:Stomach / Q000601:surgery; D016896:Treatment Outcome; D015431:Weight Loss
D001786:Blood Glucose
Ann N Y Acad Sci. 1993 Jun 14;683:102-9
8352433
Am Surg. 2004 Jan;70(1):1-4; discussion 4-5
14964537
Lancet. 2002 Mar 23;359(9311):1004-10
11937179
Obes Surg. 2005 Apr;15(4):459-61
15946422
J Clin Endocrinol Metab. 2000 Jun;85(6):2113-5
10852436
N Engl J Med. 2005 Jul 21;353(3):249-54
16034010
Diabetologia. 1991 Jul;34(7):483-7
1916053
Obes Surg. 2005 Apr;15(4):474-81
15946424
Diabetes Care. 2006 Jan;29 Suppl 1:S4-42
16373931
Diabetologia. 2004 Mar;47(3):357-366
14968296
Am J Clin Nutr. 1995 Apr;61(4 Suppl):980S-986S
7900697
BMJ. 1995 Jan 14;310(6972):83-8
7833731
Obes Surg. 1998 Jun;8(3):253-60
9678192
Br J Nutr. 2005 Apr;93 Suppl 1:S147-56
15877888
Ann Surg. 2006 Nov;244(5):741-9
17060767
Ann Surg. 2002 Nov;236(5):554-9
12409659
Obes Surg. 1999 Jun;9(3):223-8
10484306
Obes Surg. 2004 Jun-Jul;14(6):840-8
15318993
Diabetes Care. 2004 Jan;27 Suppl 1:S47-54
14693925
Lancet. 2002 Mar 9;359(9309):824-30
11897280
BMJ. 1992 May 2;304(6835):1154-5
1392794
Ann Surg. 1998 May;227(5):637-43; discussion 643-4
9605655
Ann Surg. 2003 Oct;238(4):467-84; discussion 84-5
14530719
Arch Intern Med. 1990 Apr;150(4):803-6
2327840
Biochem Biophys Res Commun. 2005 Sep 30;335(3):937-42
16105663
Nutr Clin Care. 2003 May-Sep;6(2):62-72
14692294
Ann Surg. 1995 Sep;222(3):339-50; discussion 350-2
7677463
Diabetes. 2005 Aug;54(8):2436-46
16046312
N Engl J Med. 1993 Sep 30;329(14 ):977-86
8366922
Arch Surg. 2002 Oct;137(10):1109-17
12361414
Obes Surg. 2005 Oct;15(9):1258-64
16259883
Obes Surg. 1992 Nov;2(4):303-313
10765190
Obes Surg. 2005 Apr;15(4):462-73
15946423
Vasc Med. 2002 Feb;7(1):35-43
12083733
Surgery. 1996 Mar;119(3):261-8
8619180
Ann Surg. 2003 Jun;237(6):751-6; discussion 757-8
12796570
Am J Physiol. 1989 Aug;257(2 Pt 1):E241-6
2669517
BMJ. 1998 Sep 12;317(7160):703-13
9732337
Dan Med Bull. 2004 Nov;51(4):364-70
16009062
J Clin Endocrinol Metab. 2003 Oct;88(10):4897-903
14557471
Metabolism. 2004 May;53(5):624-31
15131768
Diabetes Care. 2002 Feb;25(2):358-63
11815510
Surg Obes Relat Dis. 2006 Jul-Aug;2(4):464-7
16925382
Am J Physiol. 1996 Oct;271(4 Pt 1):G681-91
8897889
Diabetes Metab Res Rev. 2005 Mar-Apr;21(2):91-117
15759282
Obes Rev. 2004 Feb;5(1):69-78
14969508